Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized placebo-controlled study of futagliptin benzoic acid in type 2 diabetes mellitus
ChiCTR1800017909Phase 2Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of futagliptin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Peking University First Hospital. Primary endpoint: HbA1c. Started Feb 2018; status: recruiting.
02
Drugs
futagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1800017909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017909.